Your browser doesn't support javascript.
loading
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum, Patrick; Visvanathan, Sudha; Garcet, Sandra; Roy, Janine; Schmid, Ramona; Bossert, Sebastian; Lang, Benjamin; Bachelez, Hervé; Bissonnette, Robert; Thoma, Christian; Krueger, James G.
Affiliation
  • Baum P; Boehringer Ingelheim GmbH & Co KG, Biberach, Germany. Electronic address: patrick.baum@boehringer-ingelheim.com.
  • Visvanathan S; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Conn.
  • Garcet S; Laboratory for Investigative Dermatology, Rockefeller University, New York, NY.
  • Roy J; Staburo GmbH, Munich, Germany.
  • Schmid R; Boehringer Ingelheim GmbH & Co KG, Biberach, Germany.
  • Bossert S; Boehringer Ingelheim GmbH & Co KG, Biberach, Germany.
  • Lang B; Boehringer Ingelheim GmbH & Co KG, Biberach, Germany.
  • Bachelez H; UMR INSERM U1163, Institut Imagine, Université de Paris, and Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.
  • Bissonnette R; Innovaderm Research Inc, Montreal, Quebec, Canada.
  • Thoma C; Boehringer Ingelheim GmbH & Co KG, Biberach, Germany.
  • Krueger JG; Laboratory for Investigative Dermatology, Rockefeller University, New York, NY.
J Allergy Clin Immunol ; 149(4): 1402-1412, 2022 04.
Article in En | MEDLINE | ID: mdl-34678325

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Skin Diseases, Vesiculobullous / Primary Immunodeficiency Diseases Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Skin Diseases, Vesiculobullous / Primary Immunodeficiency Diseases Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2022 Document type: Article Country of publication: United States